Now showing items 1-4 of 4

    • Co-enrollment in multiple HIV prevention trials - experiences from the CAPRISA 004 Tenofovir gel trial. 

      Abdool Karim, Quarraisha.; Kharsany, Ayesha B. M.; Naidoo, Kasavan.; Yende Zuma, Nonhlanhla.; Gengiah, Tanuja N.; Omar, Zaheen.; Arulappan, Natasha.; Mlisana, Koleka Patience.; Luthuli, Londiwe R.; Abdool Karim, Salim Safurdeen. (Elsevier., 2011-05)
      Background—In settings where multiple HIV prevention trials are conducted in close proximity, trial participants may attempt to enroll in more than one trial simultaneously. Co-enrollment impacts on participant’s safety ...
    • High rates of tuberculosis in patients accessing HAART in rural South Africa. 

      Naidoo, Kogieleum.; Abdool Karim, Quarraisha.; Bhushan, Ambika.; Naidoo, Kasavan.; Yende-Zuma, Nonhlanhla.; Mchunu, Patricia K.; Frohlich, Janet A.; Karim, Farina.; Upfold, Michele.; Kocheleff, Paul.; Abdool Karim, Salim Safurdeen. (Lippincott Williams & Wilkins., 2014)
      Background: The challenge of early tuberculosis (TB) infection among rural patients accessing highly active antiretroviral therapy (HAART) in a resource-limited setting with high HIV and TB burden has not been fully ...
    • HIV-associated tuberculosis. 

      Naidoo, Kogieleum.; Naidoo, Kasavan.; Padayatchi, Nesri.; Abdool Karim, Quarraisha. (Hindawi Publishing Corporation., 2011)
      The intersecting HIV and Tuberculosis epidemics in countries with a high disease burden of both infections pose many challenges and opportunities. For patients infected with HIV in high TB burden countries, the diagnosis ...
    • The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial. 

      Naidoo, Kogieleum.; Yende Zuma, Nonhlanhla.; Padayatchi, Nesri.; Naidoo, Kasavan.; Jithoo, Niraksha.; Nair, Gonasagrie.; Bamber, Sheila.; Gengiah, Santhanalakshmi.; El-Sadr, Wafaa.; Friedland, Gerald H.; Abdool Karim, Salim Safurdeen. (American College of Physicians., 2012-09-04)
      Background: Concerns about the immune reconstitution inflammatory syndrome (IRIS) remain a barrier to antiretroviral therapy (ART) initiation during antituberculosis treatment in co-infected patients. Objective: To ...